Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin

BACKGROUND & AIMS: Some individuals with hepatitis C virus infection treated with direct‐acting antivirals require ribavirin to maximize sustained virological response rates. We describe the clinical management of ribavirin dosing in hepatitis C virus‐infected patients receiving ombitasvir/parit...

Descripción completa

Detalles Bibliográficos
Autores principales: Feld, Jordan J., Bernstein, David E., Younes, Ziad, Vlierberghe, Hans Van, Larsen, Lois, Tatsch, Fernando, Ferenci, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175401/
https://www.ncbi.nlm.nih.gov/pubmed/29377566
http://dx.doi.org/10.1111/liv.13708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175401/
https://www.ncbi.nlm.nih.gov/pubmed/29377566
http://dx.doi.org/10.1111/liv.13708

Ejemplares similares